Related Experiment Video

Updated: Aug 30, 2026

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

Immunoglobulin levels in Bull terriers suffering from lethal acrodermatitis

N A McEwan1, H P Huang, D J Mellor

  • 1Department of Veterinary Clinical Studies, Institute of Comparative Medicine, University of Glasgow Veterinary School, Bearsden, Glasgow G61 1QH, UK. n.mcewan@vet.gla.ac.uk

Veterinary Immunology and Immunopathology
|November 1, 2003
PubMed

An enzyme-linked immunosorbent assay, developed by one the authors (Huang, 1993) was used to measure immunoglobulin levels in previously stored plasma samples from eight dogs suffering from lethal acrodermatitis (LAD) and 10 normal Bull terriers. The aim of the study was to document plasma immunoglobulin levels and to determine if dogs suffering from LAD had low IgA levels. The results showed that dogs suffering from LAD had normal IgG and IgM levels but significantly lower IgA levels than the control group. This finding may in part explain the frequent occurrence of microbial infections recorded in dogs suffering from LAD.

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...